On June 19, 2019, at 1:30 PST, the Washington State Bar Association’s Cannabis Law Section will be presenting an online CLE on hemp. I’ll be... Washington CBD Webinar June 19: Hemp-Derived CBD Locally and Nationwide

washington cbd hemp fdaOn June 19, 2019, at 1:30 PST, the Washington State Bar Association’s Cannabis Law Section will be presenting an online CLE on hemp. I’ll be joined by my esteemed colleagues to shed some light on hemp laws both nationally and here in the Evergreen State. You can register to join us here.

We’ll cover a host of topics, but will start with the 2014 Farm Bill, which first allowed for the legal cultivation of industrial hemp for research purposes. Under the 2014 Farm Bill, state departments of agriculture and universities could undertake agricultural pilot programs to permit the cultivation of hemp. Some states also license the processing of hemp. The hemp industry as we know it is the result of this piece of legislation.

For more on the 2014 Farm Bill, take a look at the following:

We’ll then turn to the 2018 Farm Bill, which does not immediately repeal the 2014 Farm Bill. The 2014 Farm Bill will remain in place for at least a year after the U.S. Department of Agriculture (USDA) issues regulations under the 2018 Farm Bill. The 2018 Farm Bill’s main focus when it comes to hemp is cultivation. It provides detailed guidelines for states to create their own plans to regulate the cultivation of hemp. It also allows the USDA to set federal standards for hemp cultivation to be used in states that do not have an approved plan but also have not prohibited hemp cultivation under state law. The 2018 Farm Bill also removed hemp from the Controlled Substances Act, clarifying that hemp is a regulated agricultural commodity, not a controlled substance like marijuana.

Here is some additional reading on the 2018 Farm Bill:

At this point, we’ll talk about Washington State, where lawmakers have just overhauled the entire hemp program. The Washington State Department of Agriculture (WSDA) oversaw hemp under the 2014 Farm Bill and will continue to do so under the 2018 Farm Bill. We’ll talk about how this new legislation allows for broader commercial activities and provide insights as to how the WSDA plans to regulate the industry going forward. We’ll also cover how Washington stands to fare in the hemp-derived CBD market under this new law.

For more on Washington hemp, check out the following:

No hemp presentation would be complete without some talk about the Food and Drug Administration (FDA). The FDA regulates food, drugs, dietary supplements, cosmetics, and a whole host of other consumable goods. The FDA’s position with hemp and more specifically Hemp-CBD is. . . complicated. The FDA has said that Hemp-CBD can’t be added to food or dietary supplements and that it can only be marketed as a drug if investigated and approved as a new drug. The FDA has approved of Epidiolex, which contains CBD, for treating epilepsy. It has also determined that three hemp seed ingredients are generally regarded as safe for use in foods. Other than that, the FDA’s relationship with other CBD products has been hostile though it has not yet passed any final rules on the topic.

More on FDA is available here:

We’ll wrap up our conversation by providing some tips on how to advise businesses in this complicated space. We’ll even touch on distributing Hemp-CBD products across state lines. Our program will be focused on attorneys, who can receive CLE credits for attending, but the information that we cover is applicable for anyone operating in this market.

For some examples, take a look at the following:

Speaking on behalf of the Cannabis Law Section’s executive board, I sincerely hope you can join us! Feel free to comment below with questions you would like addressed and we’ll do our best to answer them in our presentation.

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )